PRP for Alopecia Areata: Can Autologous Plasma Help?

Hair loss can be a deeply personal experience. For those living with alopecia areata - an autoimmune condition that causes unpredictable, patchy hair loss - the emotional and psychological impact can be significant. It is entirely understandable that many patients turn to the internet in search of answers, seeking evidence-based treatments that may support hair regrowth without invasive procedures.

Platelet-rich plasma (PRP) therapy has attracted growing interest as a potential adjunctive approach for a range of hair loss conditions, including alopecia areata. Using the patient's own blood-derived plasma - hence the term autologous - PRP therapy aims to deliver concentrated growth factors directly to the scalp, with the intention of supporting the hair follicle environment.

This article explores what PRP therapy involves, what the current evidence suggests about its use in alopecia areata, who may be a suitable candidate, and what realistic expectations look like. As with any aesthetic or medical treatment, individual suitability should always be assessed by a qualified practitioner.

Can platelet-rich plasma (PRP) therapy help with alopecia areata?

PRP for alopecia areata involves injecting concentrated platelet-rich plasma, derived from the patient's own blood, into the affected scalp. The growth factors within PRP may help stimulate follicular activity and reduce local inflammation. While early research is encouraging, results vary considerably between individuals, and treatment suitability requires professional assessment.

Alopecia areata is an autoimmune condition in which the body's immune system mistakenly targets hair follicles, leading to localised or more widespread hair loss. It can affect people of any age, sex, or ethnicity and typically presents as smooth, coin-shaped patches of hair loss on the scalp, though it can also affect the beard, eyebrows, eyelashes, and body hair.

The condition can be unpredictable in its course. Some individuals experience spontaneous regrowth, while others may have recurring episodes or more extensive loss over time. The exact triggers for alopecia areata are not fully understood, though genetic predisposition and environmental factors are thought to play a role.

It is important to recognise that alopecia areata is a medical condition, and any treatment approach - whether conventional or emerging - should be discussed with a suitably qualified healthcare professional who can assess the nature and severity of the hair loss, explore appropriate management options, and determine whether adjunctive therapies such as PRP may be suitable in an individual's specific circumstances.

Platelet-rich plasma (PRP) therapy is a procedure that uses a small sample of the patient's own blood to create a concentrated plasma solution rich in platelets and growth factors. Because it is derived from the patient's own biological material, it is described as autologous - meaning there is no risk of allergic reaction to an external substance.

The procedure involves drawing a small volume of blood, processing it in a centrifuge to separate the plasma from red blood cells, and then preparing the platelet-rich fraction for injection or topical application. In the context of hair loss, PRP is typically administered through a series of micro-injections into the scalp at the level of the hair follicles.

PRP has been used in various medical and aesthetic settings for many years - including in orthopaedics, wound healing, and skin rejuvenation - and interest in its potential application for hair loss conditions has grown considerably over the past decade. For those researching broader skin and scalp health approaches, Pantaleo Clinic's skin rejuvenation treatments may offer additional context on regenerative and supportive aesthetic procedures.

To understand why PRP may be of interest in alopecia areata, it helps to appreciate the biology of the hair follicle and the mechanisms through which PRP is thought to act.

Hair follicles undergo cyclical phases of growth (anagen), regression (catagen), and rest (telogen). In alopecia areata, inflammation around the follicle - driven by immune cell activity - disrupts this cycle and places affected follicles in a prolonged resting or miniaturised state. Crucially, in most cases of alopecia areata, the follicle itself is not permanently destroyed, which is why spontaneous regrowth can occur.

Platelets, which are naturally occurring blood components, contain a range of biologically active proteins known as growth factors. These include platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor (TGF), and insulin-like growth factor (IGF). When concentrated and delivered to the scalp, these growth factors are thought to:

Promote blood vessel formation around the follicle (angiogenesis) Stimulate the dermal papilla cells that regulate hair growth Extend the anagen (active growth) phase Potentially modulate localised inflammatory activity

In simple terms, PRP may help create a more supportive biological environment around hair follicles, encouraging them to re-enter and sustain the growth phase. However, the degree to which this translates to visible regrowth in alopecia areata specifically - where immune dysregulation is a central factor - varies between individuals and remains an active area of clinical research.

The evidence base for PRP in alopecia areata is still evolving. A number of clinical studies and systematic reviews have investigated its use, with generally encouraging but variable results.

Several randomised controlled trials and observational studies have reported improvements in hair density, regrowth rates, and patient-reported outcomes following a course of PRP injections in individuals with patchy alopecia areata. Some studies have compared PRP with standard treatments such as intralesional corticosteroid injections, with some suggesting comparable or additive benefits.

That said, the quality and scale of available evidence remains limited. Study designs, PRP preparation protocols, injection techniques, patient populations, and outcome measures vary considerably across the literature, making direct comparison difficult. There is currently no universal consensus on optimal PRP concentration, injection intervals, or the number of sessions required.

It is also worth noting that because alopecia areata can fluctuate naturally - with spontaneous remission occurring in some individuals - attributing regrowth exclusively to any single treatment can be challenging. This underscores the importance of managed expectations and individualised assessment.

PRP therapy for alopecia areata is not universally suitable. Individual suitability depends on a range of factors that should be carefully evaluated during a professional consultation with a qualified practitioner.

Those who may be considered for assessment include:

Adults with patchy alopecia areata who have explored or are concurrently using other management approaches Individuals with early or moderate hair loss where follicular activity is still present Patients seeking adjunctive options alongside dermatological management Those in good general health without contraindications to the procedure

PRP therapy may be less suitable - or require careful consideration - in individuals who:

Have active scalp infections or inflammatory skin conditions at the treatment site Are taking anticoagulant medications or have coagulation disorders Have severe or total alopecia (alopecia universalis or alopecia totalis) Are pregnant or breastfeeding Have haematological conditions affecting platelet function

This list is not exhaustive. A thorough medical history, examination of the scalp, and discussion of previous treatments are all important components of an appropriate pre-treatment assessment.

Managing expectations is one of the most important aspects of any treatment discussion. For alopecia areata specifically, PRP therapy should be understood as a supportive, adjunctive approach rather than a cure or a guaranteed solution.

Some individuals report visible improvement in hair density and coverage following a course of PRP sessions, typically administered at monthly intervals over three to six months. However, responses vary considerably. Factors that may influence outcomes include:

The extent and duration of hair loss - more longstanding or extensive alopecia may respond less predictably Disease activity at the time of treatment - active, rapidly progressing alopecia areata may be more challenging to address Individual biological variation - the concentration and activity of growth factors differ between patients Adjunctive treatments - PRP is often considered alongside other dermatological management rather than as a standalone intervention

It is also worth noting that PRP therapy typically requires ongoing maintenance sessions to sustain any observed benefits. Permanent or guaranteed regrowth cannot be promised, and results may not be equivalent across different patients.

If you have noticed patchy hair loss, thinning, or changes in scalp hair density, a professional assessment is a sensible first step - not because treatment is necessarily required, but because understanding the cause of hair loss is important before exploring any management options.

A consultation with a qualified aesthetic practitioner or specialist may be particularly helpful if:

You have been experiencing recurrent or worsening episodes of patchy hair loss Previous treatments have offered limited improvement and you are researching alternatives You have questions about whether PRP or other regenerative approaches may be appropriate for your situation You wish to discuss a holistic scalp health and hair care plan

A consultation provides the opportunity to explore your medical history, discuss expectations honestly, and receive personalised guidance - without any obligation to proceed with treatment. Seeking professional advice is always encouraged over self-treating or drawing conclusions solely from online research.

Like all aesthetic and medical interventions, PRP therapy for alopecia areata carries both potential benefits and recognised limitations. Understanding both sides of this picture is essential for informed decision-making.

Potential benefits may include: Stimulation of follicular activity in suitable candidates Use of the patient's own biological material (autologous), reducing the risk of allergic reactions A relatively low-risk procedural profile when performed by a qualified practitioner A non-surgical approach that can be integrated alongside other management strategies

Limitations and considerations include: Variable and unpredictable outcomes between individuals The need for multiple treatment sessions, often on an ongoing basis Limited long-term evidence specific to alopecia areata Not suitable for all patients or all presentations of hair loss Mild discomfort during the injection process and temporary post-procedural redness or swelling

There is no single treatment for alopecia areata that works universally. PRP should be considered as part of a broader, individualised management approach discussed with an appropriate healthcare professional.

Following PRP treatment, practitioners typically provide specific aftercare guidance tailored to the individual. General considerations that are commonly discussed include:

Avoiding washing the hair or applying products to the scalp for a defined period immediately after treatment - your practitioner will advise on the recommended timeframe Avoiding vigorous physical activity for 24-48 hours post-procedure to minimise swelling or discomfort at injection sites Protecting the scalp from prolonged sun exposure, particularly in the days following treatment, using appropriate headwear Avoiding anti-inflammatory medications (such as ibuprofen) unless advised by a clinician, as these may theoretically interfere with the platelet activity that underpins PRP Maintaining general scalp hygiene with gentle, non-irritating hair care products

Beyond post-procedural care, broader scalp and hair health can be supported by a balanced diet adequate in iron, zinc, vitamin D, and protein - all of which are associated with hair follicle function. Chronic stress management and adequate sleep are also recognised as relevant factors in overall hair health.

For those exploring holistic scalp treatments alongside PRP, Pantaleo Clinic's consultation services offer an opportunity to discuss individualised approaches with a qualified practitioner.

PRP is one of several approaches that may be considered in the management of alopecia areata. For context, other commonly discussed options include:

Intralesional corticosteroid injections - a well-established dermatological treatment that suppresses localised immune activity; often considered a first-line option for patchy alopecia areata Topical immunotherapy (e.g. diphenylcyclopropenone/DPCP) - used in specialist dermatology settings for more extensive alopecia areata Minoxidil - a topical solution or foam that may support hair regrowth and is available over the counter, though it does not address the underlying autoimmune process JAK inhibitors - an emerging class of systemic medications showing promise for alopecia areata, currently the subject of significant clinical research Microneedling - sometimes used in conjunction with PRP or as a standalone approach to support scalp stimulation

PRP is generally considered an adjunctive rather than a replacement for established dermatological treatments. Patients are encouraged to discuss all available options - and their relative evidence bases - with a suitably qualified healthcare professional who can consider their individual circumstances. Those researching regenerative aesthetic treatments may also find it helpful to explore polynucleotide (PDRN) therapy information at Pantaleo Clinic, as it is another biologically derived option sometimes discussed in the context of tissue support and regeneration.

PRP (platelet-rich plasma) therapy uses the patient's own blood-derived plasma to deliver growth factors to the scalp, with the aim of supporting follicular activity in alopecia areata. The evidence is encouraging but still evolving - clinical studies suggest variable but potentially meaningful improvements in some patients, though outcomes are not guaranteed or universal. Alopecia areata is an autoimmune condition, and PRP is best considered as an adjunctive approach rather than a standalone cure. Individual suitability must be assessed by a qualified practitioner, taking into account the nature of hair loss, medical history, and treatment goals. Multiple sessions are typically required, with ongoing maintenance often needed to sustain any observed benefits. Realistic expectations are essential - PRP may support the follicular environment, but results vary considerably between individuals.

How many PRP sessions are typically needed for alopecia areata?

Most practitioners discuss an initial course of three to six sessions, usually spaced approximately four weeks apart, followed by maintenance treatments every three to six months depending on response. However, there is no universally agreed protocol. The number of sessions recommended will depend on the individual's presentation, the extent of hair loss, and how they respond to initial treatment. This should be discussed thoroughly during a professional consultation, where a plan tailored to your specific needs can be developed.

Is PRP therapy for alopecia areata painful?

Patients commonly experience mild discomfort during the injection process, as the scalp contains numerous nerve endings. Many practitioners use topical anaesthetic cream applied beforehand to reduce discomfort. Post-treatment, some patients report temporary tenderness, redness, or swelling at the injection sites, which typically resolves within 24-48 hours. Pain tolerance varies between individuals, and your practitioner should discuss what to expect during and after the procedure so you feel informed and prepared.

Are there any risks associated with PRP scalp injections?

Because PRP is derived from the patient's own blood, the risk of allergic reaction to the plasma itself is considered low. However, as with any injectable procedure, there are procedural risks including temporary swelling, bruising, or redness at the injection sites. In rare instances, infection is possible if appropriate sterile technique is not observed. It is important that PRP is administered by a suitably qualified and experienced practitioner in a clinical environment, where safety protocols are properly maintained.

Can PRP help with total hair loss (alopecia universalis or alopecia totalis)?

PRP therapy is generally considered more relevant for patchy or localised alopecia areata where some follicular activity may remain. In cases of extensive or total hair loss (alopecia totalis or alopecia universalis), the evidence for PRP is considerably more limited, and alternative management approaches may be more appropriate. Individuals with extensive alopecia areata should seek assessment from a qualified dermatologist or specialist to discuss the most evidence-based options for their specific situation.

How long does it take to see results from PRP for hair loss?

Results, where they occur, are generally not immediate. Some patients begin to notice changes in hair quality, density, or new growth after two to three months of treatment, though the timeline varies considerably between individuals. The natural hair growth cycle means that visible changes take time to manifest. It is important to approach the treatment with patience and to maintain open communication with your practitioner throughout the process, so that progress can be monitored and the treatment plan adjusted if needed.

Can PRP for alopecia areata be combined with other treatments?

PRP is frequently discussed as an adjunctive therapy that may complement other management approaches for alopecia areata, rather than replacing them. Some practitioners may discuss combining PRP with treatments such as intralesional corticosteroids, topical minoxidil, or microneedling, depending on the individual's circumstances. Any combination approach should be carefully planned and supervised by a qualified practitioner who is familiar with the patient's medical history and treatment goals, to ensure safety and appropriateness.

Alopecia areata is a complex autoimmune condition that can have a meaningful impact on wellbeing and quality of life. PRP therapy - using autologous, platelet-rich plasma derived from the patient's own blood - represents an increasingly discussed adjunctive option that may help support the follicular environment and encourage hair regrowth in some individuals.

The science behind PRP is biologically plausible, and the emerging clinical evidence is encouraging, though the research is still maturing and outcomes remain variable. PRP should be understood as one component of a broader, personalised approach to hair loss management - not as a guaranteed solution or a replacement for established dermatological treatments.

If you are considering PRP for alopecia areata, the most important first step is to seek a professional consultation with a suitably qualified practitioner who can assess your specific circumstances, discuss the available evidence, and help you understand whether this approach may be appropriate for you.

Treatment suitability, risks, and expected outcomes should always be assessed individually during a professional consultation.

This article is intended for general educational purposes only and does not constitute personalised medical or aesthetic advice. Individual treatment recommendations, suitability assessments, and expected outcomes require consultation with a qualified healthcare professional.

Written Date: 13th July 2026 Next Review Date: 13th July 2027